Filed under Biosimilar Drug Regulations

Patents in Malaysia: Intellectual Property Guide for Filing Patents in Malaysia

Patents in Malaysia: Intellectual Property Guide for Filing Patents in Malaysia

Article Source: http://wp.me/p2PCVq-DG Patents in Malaysia are governed by Intellectual Property Cooperation of Malaysia (MyIPO). Industries, corporations and individual researchers (inventors) involved in R & D (research and development) in Malaysia regularly seek professional services of technically qualified industrial patent experts for supporting research and development activities, patent consultancy, technology transfer, patent strategy, franchising, patent … Continue reading

Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India

Patent Expiration & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India Article Source: http://techcorplegal.com/Startup_Business/Blog/biosimilars_regulatory.html Earlier this year, in Feb. 2012, FDA issued draft guidance on biosimilar product development, and The Patient Protection and Affordable Care Act, which was signed into law by President Obama on March 23, 2010, amended the Public Health Service Act to create … Continue reading